Acute pulmonary embolism(APE)is one of the common acute and critical cardiovascular diseases.Currently,the methods used to diagnose APE rely on imaging and laboratory tests.The commonly used imaging detection methods are complex,consuming time,inconvenient handling for acute and severe pa-tients and high examination cost.Therefore,exploring a simple,economical and effective evaluation method for acute non-high-risk pulmonary embolism patients has important clinical significance.Immune/inflammatory response plays an important role in the pathogenesis of vascular disease.Representative indicators in blood in-clude neutrophil/lymphocyte ratio,monocyte-related indicators,platelet/lymphocyte ratio,systemic immune/inflammatory index,etc.This paper focused on the value of novel inflammatory markers in predicting the diag-nosis and prognosis of APE patients.
维普
万方数据